MOMENTA PHARMACEUTICALS INC — Operating Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/29a60b01-04db-41b0-93f3-71c5cd96a252/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-298.1M | 2019-01-01 – 2019-12-31 | evidence 0001235010-20-000003 |
| FY 2018 | $-181.3M | 2018-01-01 – 2018-12-31 | evidence 0001235010-19-000002 |
| FY 2017 | $-92.6M | 2017-01-01 – 2017-12-31 | evidence 0001235010-18-000004 |
| FY 2016 | $-74.7M | 2016-01-01 – 2016-12-31 | evidence 0001235010-17-000003 |
| FY 2015 | $-84.4M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010502 |
| FY 2014 | $-99.4M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-001399 |
| FY 2013 | $-109.6M | 2013-01-01 – 2013-12-31 | evidence 0001047469-14-001572 |
| FY 2012 | $-60.1M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-001950 |
| FY 2011 | $179.7M | 2011-01-01 – 2011-12-31 | evidence 0001047469-12-001705 |
| FY 2010 | $36.5M | 2010-01-01 – 2010-12-31 | evidence 0001047469-12-001705 |
| FY 2009 | $-64.2M | 2009-01-01 – 2009-12-31 | evidence 0001047469-12-001705 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).